Perspective: emerging challenges in the treatment of influenza and parainfluenza in transplant patients.
Influenza, respiratory synctial virus, and parainfluenza are common respiratory infections in immunocompromised transplant recipients, causing significant morbidity and mortality in this patient population. This paper focuses on influenza and parainfluenza virus infections in transplant patients with emphasis on the pandemic 2009 H1N1 influenza infection. Current antiviral treatment recommendations for influenza and parainfluenza in immunocompromised patients as well as novel investigational therapeutic approaches currently being tested in the clinic are discussed. In addition to the morbidity and mortality caused by these viruses, the development of multidrug resistance leading to transmission of resistant viruses is of great public health concern. The development of effective new therapies for influenza and parainfluenza in these high-risk patients is needed with randomized placebo-controlled studies to assess their clinical utility.
NexBio Inc., 10665 Sorrento Valley Road, San Diego, CA 92121, USA.
Ronald B
RB
Moss
Roy T
RT
Steigbigel
Rebecca L
RL
Sanders
Fang
F
Fang